WNT1-inducible signaling pathway protein 1 regulates kidney inflammation through the NF-κB pathway

Bo Wang1,2, Chenguang Ding1,3, Xiaoming Ding1,3

  • 1Department of Kidney Transplantation, Nephropathy Hospital, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

Insights

WNT1-inducible signaling pathway protein 1 (WISP1) drives kidney inflammation by activating nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB). Blocking WISP1 shows potential for treating kidney disease by reducing inflammation.

Area of Science:

  • Nephrology
  • Immunology
  • Molecular Biology

Background:

  • Kidney inflammation is a key factor in kidney injury progression and fibrosis.
  • The role of WNT1-inducible signaling pathway protein 1 (WISP1) in kidney inflammation requires further investigation.

Purpose of the Study:

  • To investigate the regulatory function of WISP1 in kidney inflammation.
  • To explore the potential of targeting WISP1 as a therapeutic strategy for kidney disease.

Main Methods:

  • Administration of recombinant WISP1 protein and WISP1 inhibition (gene knockdown, neutralizing antibody) in mouse models.
  • Assessment of inflammatory markers (macrophage accrual, TNF-α, CCL2, IL-6) and NF-κB signaling.
  • Evaluation in unilateral ureter obstruction (UUO) and streptozotocin (STZ)-induced diabetic nephropathy (DN) models.

Main Results:

  • Recombinant WISP1 induced kidney inflammation, mediated by NF-κB signaling.
  • WISP1 inhibition reduced inflammatory cytokine production in macrophages and fibroblast proliferation.
  • WISP1 expression was elevated in UUO and STZ-induced DN mouse models.
  • WISP1 antibody treatment decreased kidney inflammation in UUO mice.

Conclusions:

  • WISP1 promotes kidney inflammation through NF-κB signaling.
  • Pharmacological blockade of WISP1 presents a potential novel therapeutic approach for kidney inflammation in kidney diseases.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.2K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.7K